More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

Ethics Approval Received For Multi-Centre Clinical Trial

Oct 3, 2022 at 9:22 PM EDT · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Oct 3, 2022 at 9:22 PM EDT

On 6ix: 6ix.com/news/ethics-approval-received-for-multi-centre-clinical-trial

Emvision Medical Devices Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

EMvision Medical Devices Ltd. on 6ix

Earlier from EMvision Medical Devices

  • Employee Incentive Plan IssueSep 16, 2022
  • Appendix 4E & Annual Report to 30 June 2022Aug 29, 2022
  • $5m Modern Manufacturing Initiative Grant ProceedingAug 28, 2022
  • Centres of Excellence Confirmed as First Two Clinical SitesJul 11, 2022
  • EMVision Achieves First Responder MilestoneJun 26, 2022

Later from EMvision Medical Devices

  • $5m Modern Manufacturing Initiative Funding Agreement SignedOct 24, 2022
  • EMVision Backed By NSW Medical Devices Fund With $2.5m GrantNov 10, 2022
  • Portable Brain Scanner Delivered to First Clinical SiteNov 13, 2022
  • AGM Chairman Address and PresentationNov 15, 2022
  • EMVision Commences Clinical TrialNov 29, 2022
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer